Tesamorelin

GHRH analogue approved for HIV-associated lipodystrophy. Reduces visceral fat accumulation through sustained GH stimulation; available as Egrifta.

2 anonymous reports
Peptides for Weight LossPeptides for Muscle GrowthTesamorelinSuccess Stories

Also known as:

egriftatesamorelin acetate

browse topics:

Peptides for Muscle Growth

community guides:

Growth Hormone PeptidesBest Peptide StacksReconstituting PeptidesInjecting Peptides

Tesamorelin almost killed me. was my first injection ever and my body fully shut down, full anaphylactic cardiac collapse. It took 2 epi pens and massive doses of other meds, including dexamethasone, to keep me alive. Please do your research and due dilligence

#107
Peptides for Weight LossPeptides for Muscle GrowthTesamorelin

5. Tesamorelin is the one nobody talks about for visceral fat specifically. lost 2 inches off my waist in 8 weeks with zero scale movement. it doesn't drop your weight, it redistributes where the fat sits. if your gut is the problem and not the number, this is the one.

#081
Success StoriesPeptides for Weight LossPeptides for Muscle GrowthTesamorelin

Community Q&A

What is tesamorelin used for?
Community accounts split between its FDA-approved use (HIV-associated lipodystrophy) and general body composition goals. For lipodystrophy accounts, tesamorelin is described as producing significant visceral fat reduction over 3–6 months — a distinct and meaningful outcome for users affected by HIV medication-related fat redistribution. For general use accounts, tesamorelin is framed as a GHRH analogue producing visceral fat reduction and GH stimulation similar to sermorelin but with a stronger evidence base and more predictable response.
How does tesamorelin compare to sermorelin?
Community accounts that have used both describe tesamorelin as producing a stronger and more consistent GH response, particularly for visceral fat reduction. Sermorelin accounts tend to be more general and wellness-focused; tesamorelin accounts are more frequently targeted at specific visceral fat concerns. Cost is consistently cited in tesamorelin accounts — it is more expensive than sermorelin, limiting its use to those with specific therapeutic goals. Both are described as gradual compounds requiring months for full effect.